(Q37112199)

18 August 2017

1 reference

title

The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells (English)

1 reference

18 August 2017

Huanfa Yi

1

1 reference

18 August 2017

Jialin Zhang

series ordinal

2

1 reference

18 August 2017

Yong Zhao

series ordinal

3

1 reference

18 August 2017

publication date

28 December 2007

1 reference

18 August 2017

published in

Transplant Immunology

1 reference

18 August 2017

volume

19

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

37-44

1 reference

Organ transplantation--how much of the promise has been realized?

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Mixed chimerism and transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The complementary roles of deletion and regulation in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Regulatory T cells in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Tregs and transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

A Novel Means of Favorably Tipping the Balance between Cytopathic and Regulatory T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

How do monoclonal antibodies induce tolerance? A role for infectious tolerance?

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Anti-CD45RB monoclonal antibody-mediated transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD3-specific antibody-induced active tolerance: from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

T cell tolerance induced by therapeutic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Antibody-induced transplantation tolerance: the role of dominant regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Regulatory T cells in immunologic self-tolerance and autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The molecular mechanisms of veto mediated regulation of alloresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Development and selection of NKT cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Regulatory T cells: friend or foe in immunity to infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Revival of the regulatory T cell: new targets for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Type 1 T Regulatory Cells and Their Relationship with CD4+ CD25+ T Regulatory Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Control of T-cell activation by CD4+ CD25+ suppressor T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Oral exposure to alloantigen generates intragraft CD8+ regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Comment on "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Rituximab: a promising therapy in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Anti-CD4 monoclonal antibody therapy in human autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Altered proximal T-cell receptor signalling events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal antibodies: evidence for reduced phosphorylation of Zap-70 and LAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cell surface antigen and molecular targeting in the treatment of hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Humanised monoclonal antibody therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

The balance of deletion and regulation in allograft tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Tracking the immunoregulatory mechanisms active during allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Combination of donor-specific blood transfusion with anti-CD28 antibody synergizes to prolong graft survival in rat liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.12.001

10.1016/J.TRIM.2007.12.001

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference